143 related articles for article (PubMed ID: 16961669)
1. Cognitive-behavioural stress management does not improve biological cardiovascular risk indicators in women with ischaemic heart disease: a randomized-controlled trial.
Claesson M; Birgander LS; Jansson JH; Lindahl B; Burell G; Asplund K; Mattsson C
J Intern Med; 2006 Oct; 260(4):320-31. PubMed ID: 16961669
[TBL] [Abstract][Full Text] [Related]
2. Changes in plasma C-reactive protein and hemostatic factors prior to and after a first myocardial infarction with a median follow-up time of 8 years.
Thøgersen AM; Nilsson TK; Weinehall L; Boman K; Eliasson M; Hallmans G; Jansson JH
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):340-6. PubMed ID: 19357504
[TBL] [Abstract][Full Text] [Related]
3. Is visceral adipose tissue a determinant of von Willebrand factor in overweight and obese premenopausal women?
Mertens I; Van der Planken M; Corthouts B; Van Gaal LF
Metabolism; 2006 May; 55(5):650-5. PubMed ID: 16631442
[TBL] [Abstract][Full Text] [Related]
4. Effects of an expanded cardiac rehabilitation programme in patients treated for an acute myocardial infarction or a coronary artery by-pass graft operation.
Plüss CE; Karlsson MR; Wallen N; Billing E; Held C
Clin Rehabil; 2008 Apr; 22(4):306-18. PubMed ID: 18390974
[TBL] [Abstract][Full Text] [Related]
5. Improved fibrinolysis after one year of treatment with enalapril in men and women with uncomplicated myocardial infarction.
Boman KO; Jansson JH; Nyhlén KA; Nilsson TK
Thromb Haemost; 2002 Feb; 87(2):311-6. PubMed ID: 11859853
[TBL] [Abstract][Full Text] [Related]
6. The effect of initial treatment of periodontitis on systemic markers of inflammation and cardiovascular risk: a randomized controlled trial.
Taylor B; Tofler G; Morel-Kopp MC; Carey H; Carter T; Elliott M; Dailey C; Villata L; Ward C; Woodward M; Schenck K
Eur J Oral Sci; 2010 Aug; 118(4):350-6. PubMed ID: 20662907
[TBL] [Abstract][Full Text] [Related]
7. The impact of metabolic syndrome and CRP on vascular phenotype in type 2 diabetes mellitus.
Alizadeh Dehnavi R; Beishuizen ED; van de Ree MA; Le Cessie S; Huisman MV; Kluft C; Princen HM; Tamsma JT
Eur J Intern Med; 2008 Mar; 19(2):115-21. PubMed ID: 18249307
[TBL] [Abstract][Full Text] [Related]
8. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
Lahlou-Laforet K; Alhenc-Gelas M; Pornin M; Bydlowski S; Seigneur E; Benetos A; Kierzin JM; Scarabin PY; Ducimetiere P; Aiach M; Guize L; Consoli SM
Am J Cardiol; 2006 May; 97(9):1287-91. PubMed ID: 16635597
[TBL] [Abstract][Full Text] [Related]
9. Low level of tissue plasminogen activator activity in non-diabetic patients with a first myocardial infarction.
Lundblad D; Dinesen B; Rautio A; Røder ME; Eliasson M
J Intern Med; 2005 Jul; 258(1):13-20. PubMed ID: 15953128
[TBL] [Abstract][Full Text] [Related]
10. Effects of a stress management program on vital exhaustion and depression in women with coronary heart disease: a randomized controlled intervention study.
Koertge J; Janszky I; Sundin O; Blom M; Georgiades A; László KD; Alinaghizadeh H; Ahnve S
J Intern Med; 2008 Mar; 263(3):281-93. PubMed ID: 18067552
[TBL] [Abstract][Full Text] [Related]
11. Sex-related differences in the associations between hyperleptinemia, insulin resistance and dysfibrinolysis.
Eriksson MA; Rask E; Johnson O; Carlström K; Ahrén B; Eliasson M; Boman K; Söderberg S
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):625-32. PubMed ID: 18832901
[TBL] [Abstract][Full Text] [Related]
12. Endothelial haemostatic factors are associated with progression of urinary albumin excretion in clinically healthy subjects: a 4-year prospective study.
Clausen P; Feldt-Rasmussen B; Jensen G; Jensen JS
Clin Sci (Lond); 1999 Jul; 97(1):37-43. PubMed ID: 10369792
[TBL] [Abstract][Full Text] [Related]
13. Tissue plasminogen activator, von Willebrand factor, and risk of type 2 diabetes in older men.
Wannamethee SG; Sattar N; Rumley A; Whincup PH; Lennon L; Lowe GD
Diabetes Care; 2008 May; 31(5):995-1000. PubMed ID: 18235054
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study.
Hanefeld M; Marx N; Pfützner A; Baurecht W; Lübben G; Karagiannis E; Stier U; Forst T
J Am Coll Cardiol; 2007 Jan; 49(3):290-7. PubMed ID: 17239709
[TBL] [Abstract][Full Text] [Related]
15. The complex between tPA and PAI-1: risk factor for myocardial infarction as studied in the SHEEP project.
Nordenhem A; Leander K; Hallqvist J; de Faire U; Sten-Linder M; Wiman B
Thromb Res; 2005; 116(3):223-32. PubMed ID: 15935831
[TBL] [Abstract][Full Text] [Related]
16. sP-selectin plasma levels in obesity: association with insulin resistance and related metabolic and prothrombotic factors.
De Pergola G; Pannacciulli N; Coviello M; Scarangella A; Di Roma P; Caringella M; Venneri MT; Quaranta M; Giorgino R
Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):227-32. PubMed ID: 17400434
[TBL] [Abstract][Full Text] [Related]
17. Comparison of soluble thrombomodulin, von Willebrand factor, tPA/PAI-1 complex, and high-sensitivity CRP concentrations in serum, EDTA plasma, citrated plasma, and acidified citrated plasma (Stabilyte) stored at -70 degrees C for 8-11 years.
Nilsson TK; Boman K; Jansson JH; Thøgersen AM; Berggren M; Broberg A; Granlund A
Thromb Res; 2005; 116(3):249-54. PubMed ID: 15935834
[TBL] [Abstract][Full Text] [Related]
18. Periodontitis is characterized by elevated PAI-1 activity.
Bizzarro S; van der Velden U; ten Heggeler JM; Leivadaros E; Hoek FJ; Gerdes VE; Bakker SJ; Gans RO; Ten Cate H; Loos BG
J Clin Periodontol; 2007 Jul; 34(7):574-80. PubMed ID: 17535288
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of cardiovascular risk factors with partial biochemical control of acromegaly.
Delaroudis SP; Efstathiadou ZA; Koukoulis GN; Kita MD; Farmakiotis D; Dara OG; Goulis DG; Makedou A; Makris P; Slavakis A; Avramides AI
Clin Endocrinol (Oxf); 2008 Aug; 69(2):279-84. PubMed ID: 18194486
[TBL] [Abstract][Full Text] [Related]
20. Short-term effects of two continuous combined oestrogen-progestogen therapies on several cardiovascular risk markers in healthy postmenopausal women: a randomised controlled trial.
de Kraker AT; Kenemans P; Smolders RG; Kroeks MV; van der Mooren MJ
Eur J Obstet Gynecol Reprod Biol; 2009 Feb; 142(2):139-44. PubMed ID: 19095343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
